Skip to main content
NCBI home page
The BMJ logoLink to The BMJ
. 1988 Oct 1;297(6652):807–810. doi: 10.1136/bmj.297.6652.807

Recent research on the causes of Alzheimer's disease.

I J Deary 1, L J Whalley 1
PMCID: PMC1834577  PMID: 3140933

Full text

PDF
807

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Annerén G., Gardner A., Lundin T. Increased glutathione peroxidase activity in erythrocytes in patients with Alzheimer's disease/senile dementia of Alzheimer's type. Acta Neurol Scand. 1986 Jun;73(6):586–589. doi: 10.1111/j.1600-0404.1986.tb04604.x. [DOI] [PubMed] [Google Scholar]
  2. Appel S. H. A unifying hypothesis for the cause of amyotrophic lateral sclerosis, parkinsonism, and Alzheimer disease. Ann Neurol. 1981 Dec;10(6):499–505. doi: 10.1002/ana.410100602. [DOI] [PubMed] [Google Scholar]
  3. Calne D. B., Eisen A., McGeer E., Spencer P. Alzheimer's disease, Parkinson's disease, and motoneurone disease: abiotrophic interaction between ageing and environment? Lancet. 1986 Nov 8;2(8515):1067–1070. doi: 10.1016/s0140-6736(86)90469-1. [DOI] [PubMed] [Google Scholar]
  4. Candy J. M., Oakley A. E., Klinowski J., Carpenter T. A., Perry R. H., Atack J. R., Perry E. K., Blessed G., Fairbairn A., Edwardson J. A. Aluminosilicates and senile plaque formation in Alzheimer's disease. Lancet. 1986 Feb 15;1(8477):354–357. doi: 10.1016/s0140-6736(86)92319-6. [DOI] [PubMed] [Google Scholar]
  5. Chase T. N., Fedio P., Foster N. L., Brooks R., Di Chiro G., Mansi L. Wechsler Adult Intelligence Scale performance. Cortical localization by fluorodeoxyglucose F 18-positron emission tomography. Arch Neurol. 1984 Dec;41(12):1244–1247. doi: 10.1001/archneur.1984.04050230026012. [DOI] [PubMed] [Google Scholar]
  6. Cohen B. M., Zubenko G. S. Aging and the biophysical properties of cell membranes. Life Sci. 1985 Oct 14;37(15):1403–1409. doi: 10.1016/0024-3205(85)90079-7. [DOI] [PubMed] [Google Scholar]
  7. Commentaries: Aluminum and Alzheimer's disease. Neurobiol Aging. 1986 Nov-Dec;7(6):532–559. [PubMed] [Google Scholar]
  8. Coyle J. T., Price D. L., DeLong M. R. Alzheimer's disease: a disorder of cortical cholinergic innervation. Science. 1983 Mar 11;219(4589):1184–1190. doi: 10.1126/science.6338589. [DOI] [PubMed] [Google Scholar]
  9. Crapper D. R., Krishnan S. S., Quittkat S. Aluminium, neurofibrillary degeneration and Alzheimer's disease. Brain. 1976 Mar;99(1):67–80. doi: 10.1093/brain/99.1.67. [DOI] [PubMed] [Google Scholar]
  10. Davies P., Katzman R., Terry R. D. Reduced somatostatin-like immunoreactivity in cerebral cortex from cases of Alzheimer disease and Alzheimer senile dementa. Nature. 1980 Nov 20;288(5788):279–280. doi: 10.1038/288279a0. [DOI] [PubMed] [Google Scholar]
  11. De Souza E. B., Whitehouse P. J., Kuhar M. J., Price D. L., Vale W. W. Reciprocal changes in corticotropin-releasing factor (CRF)-like immunoreactivity and CRF receptors in cerebral cortex of Alzheimer's disease. Nature. 1986 Feb 13;319(6054):593–595. doi: 10.1038/319593a0. [DOI] [PubMed] [Google Scholar]
  12. Deary I. J., Powell K. Fetal postsynaptic densities have mineral spectra similar to those found in amyotrophic lateral sclerosis and parkinsonism-dementia of Guam. Lancet. 1986 Mar 15;1(8481):619–620. doi: 10.1016/s0140-6736(86)92844-8. [DOI] [PubMed] [Google Scholar]
  13. Delabar J. M., Goldgaber D., Lamour Y., Nicole A., Huret J. L., de Grouchy J., Brown P., Gajdusek D. C., Sinet P. M. Beta amyloid gene duplication in Alzheimer's disease and karyotypically normal Down syndrome. Science. 1987 Mar 13;235(4794):1390–1392. doi: 10.1126/science.2950593. [DOI] [PubMed] [Google Scholar]
  14. Fischer W., Wictorin K., Björklund A., Williams L. R., Varon S., Gage F. H. Amelioration of cholinergic neuron atrophy and spatial memory impairment in aged rats by nerve growth factor. Nature. 1987 Sep 3;329(6134):65–68. doi: 10.1038/329065a0. [DOI] [PubMed] [Google Scholar]
  15. Gajdusek D. C., Salazar A. M. Amyotrophic lateral sclerosis and parkinsonian syndromes in high incidence among the Auyu and Jakai people of West New Guinea. Neurology. 1982 Feb;32(2):107–126. doi: 10.1212/wnl.32.2.107. [DOI] [PubMed] [Google Scholar]
  16. Garruto R. M., Yanagihara R., Gajdusek D. C. Disappearance of high-incidence amyotrophic lateral sclerosis and parkinsonism-dementia on Guam. Neurology. 1985 Feb;35(2):193–198. doi: 10.1212/wnl.35.2.193. [DOI] [PubMed] [Google Scholar]
  17. Glenner G. G., Wong C. W. Alzheimer's disease and Down's syndrome: sharing of a unique cerebrovascular amyloid fibril protein. Biochem Biophys Res Commun. 1984 Aug 16;122(3):1131–1135. doi: 10.1016/0006-291x(84)91209-9. [DOI] [PubMed] [Google Scholar]
  18. Goldgaber D., Lerman M. I., McBride O. W., Saffiotti U., Gajdusek D. C. Characterization and chromosomal localization of a cDNA encoding brain amyloid of Alzheimer's disease. Science. 1987 Feb 20;235(4791):877–880. doi: 10.1126/science.3810169. [DOI] [PubMed] [Google Scholar]
  19. Goudsmit J., Morrow C. H., Asher D. M., Yanagihara R. T., Masters C. L., Gibbs C. J., Jr, Gajdusek D. C. Evidence for and against the transmissibility of Alzheimer disease. Neurology. 1980 Sep;30(9):945–950. doi: 10.1212/wnl.30.9.945. [DOI] [PubMed] [Google Scholar]
  20. Haxby J. V., Grady C. L., Duara R., Schlageter N., Berg G., Rapoport S. I. Neocortical metabolic abnormalities precede nonmemory cognitive defects in early Alzheimer's-type dementia. Arch Neurol. 1986 Sep;43(9):882–885. doi: 10.1001/archneur.1986.00520090022010. [DOI] [PubMed] [Google Scholar]
  21. Hefti F., Weiner W. J. Nerve growth factor and Alzheimer's disease. Ann Neurol. 1986 Sep;20(3):275–281. doi: 10.1002/ana.410200302. [DOI] [PubMed] [Google Scholar]
  22. Heston L. L., Mastri A. R., Anderson V. E., White J. Dementia of the Alzheimer type. Clinical genetics, natural history, and associated conditions. Arch Gen Psychiatry. 1981 Oct;38(10):1085–1090. doi: 10.1001/archpsyc.1981.01780350019001. [DOI] [PubMed] [Google Scholar]
  23. Iqbal K., Grundke-Iqbal I., Wisniewski H. M. Alzheimer's disease, microtubule and neurofilament proteins, and axoplasmic flow. Lancet. 1987 Jan 10;1(8524):102–102. doi: 10.1016/s0140-6736(87)91937-4. [DOI] [PubMed] [Google Scholar]
  24. Iqbal K., Grundke-Iqbal I., Zaidi T., Merz P. A., Wen G. Y., Shaikh S. S., Wisniewski H. M., Alafuzoff I., Winblad B. Defective brain microtubule assembly in Alzheimer's disease. Lancet. 1986 Aug 23;2(8504):421–426. doi: 10.1016/s0140-6736(86)92134-3. [DOI] [PubMed] [Google Scholar]
  25. KALLMANN F. J., FEINGOLD L., BONDY E. Comparative adaptational, social, and psychometric data on the life histories of senescent twin pairs. Am J Hum Genet. 1951 Mar;3(1):65–73. [PMC free article] [PubMed] [Google Scholar]
  26. Kosik K. S., Duffy L. K., Dowling M. M., Abraham C., McCluskey A., Selkoe D. J. Microtubule-associated protein 2: monoclonal antibodies demonstrate the selective incorporation of certain epitopes into Alzheimer neurofibrillary tangles. Proc Natl Acad Sci U S A. 1984 Dec;81(24):7941–7945. doi: 10.1073/pnas.81.24.7941. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Kurland L. T. Amyotrophic lateral sclerosis and Parkinson's disease complex on Guam linked to an environmental neurotoxin. Trends Neurosci. 1988 Feb;11(2):51–54. doi: 10.1016/0166-2236(88)90163-4. [DOI] [PubMed] [Google Scholar]
  28. Liao Y. C., Lebo R. V., Clawson G. A., Smuckler E. A. Human prion protein cDNA: molecular cloning, chromosomal mapping, and biological implications. Science. 1986 Jul 18;233(4761):364–367. doi: 10.1126/science.3014653. [DOI] [PubMed] [Google Scholar]
  29. Marklund S. L., Adolfsson R., Gottfries C. G., Winblad B. Superoxide dismutase isoenzymes in normal brains and in brains from patients with dementia of Alzheimer type. J Neurol Sci. 1985 Mar;67(3):319–325. doi: 10.1016/0022-510x(85)90156-x. [DOI] [PubMed] [Google Scholar]
  30. Martins R. N., Harper C. G., Stokes G. B., Masters C. L. Increased cerebral glucose-6-phosphate dehydrogenase activity in Alzheimer's disease may reflect oxidative stress. J Neurochem. 1986 Apr;46(4):1042–1045. doi: 10.1111/j.1471-4159.1986.tb00615.x. [DOI] [PubMed] [Google Scholar]
  31. Masters C. L., Simms G., Weinman N. A., Multhaup G., McDonald B. L., Beyreuther K. Amyloid plaque core protein in Alzheimer disease and Down syndrome. Proc Natl Acad Sci U S A. 1985 Jun;82(12):4245–4249. doi: 10.1073/pnas.82.12.4245. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. McDermott J. R., Fraser H., Dickinson A. G. Reduced choline-acetyltransferase activity in scrapie mouse brain. Lancet. 1978 Aug 5;2(8084):318–319. doi: 10.1016/s0140-6736(78)91722-1. [DOI] [PubMed] [Google Scholar]
  33. McLachlan D. R. Aluminum and Alzheimer's disease. Neurobiol Aging. 1986 Nov-Dec;7(6):525–532. doi: 10.1016/0197-4580(86)90102-8. [DOI] [PubMed] [Google Scholar]
  34. Mortimer J. A., French L. R., Hutton J. T., Schuman L. M. Head injury as a risk factor for Alzheimer's disease. Neurology. 1985 Feb;35(2):264–267. doi: 10.1212/wnl.35.2.264. [DOI] [PubMed] [Google Scholar]
  35. Munoz-Garcia D., Pendlebury W. W., Kessler J. B., Perl D. P. An immunocytochemical comparison of cytoskeletal proteins in aluminum-induced and Alzheimer-type neurofibrillary tangles. Acta Neuropathol. 1986;70(3-4):243–248. doi: 10.1007/BF00686078. [DOI] [PubMed] [Google Scholar]
  36. Nee L. E., Eldridge R., Sunderland T., Thomas C. B., Katz D., Thompson K. E., Weingartner H., Weiss H., Julian C., Cohen R. Dementia of the Alzheimer type: clinical and family study of 22 twin pairs. Neurology. 1987 Mar;37(3):359–363. doi: 10.1212/wnl.37.3.359. [DOI] [PubMed] [Google Scholar]
  37. Oliver C., Holland A. J. Down's syndrome and Alzheimer's disease: a review. Psychol Med. 1986 May;16(2):307–322. doi: 10.1017/s0033291700009120. [DOI] [PubMed] [Google Scholar]
  38. Perl D. P., Brody A. R. Alzheimer's disease: X-ray spectrometric evidence of aluminum accumulation in neurofibrillary tangle-bearing neurons. Science. 1980 Apr 18;208(4441):297–299. doi: 10.1126/science.7367858. [DOI] [PubMed] [Google Scholar]
  39. Perl D. P., Gajdusek D. C., Garruto R. M., Yanagihara R. T., Gibbs C. J. Intraneuronal aluminum accumulation in amyotrophic lateral sclerosis and Parkinsonism-dementia of Guam. Science. 1982 Sep 10;217(4564):1053–1055. doi: 10.1126/science.7112111. [DOI] [PubMed] [Google Scholar]
  40. Peterson C., Gibson G. E. Aging and 3,4-diaminopyridine alter synaptosomal calcium uptake. J Biol Chem. 1983 Oct 10;258(19):11482–11486. [PubMed] [Google Scholar]
  41. Peterson C., Goldman J. E. Alterations in calcium content and biochemical processes in cultured skin fibroblasts from aged and Alzheimer donors. Proc Natl Acad Sci U S A. 1986 Apr;83(8):2758–2762. doi: 10.1073/pnas.83.8.2758. [DOI] [PMC free article] [PubMed] [Google Scholar]
  42. Podlisny M. B., Lee G., Selkoe D. J. Gene dosage of the amyloid beta precursor protein in Alzheimer's disease. Science. 1987 Oct 30;238(4827):669–671. doi: 10.1126/science.2960019. [DOI] [PubMed] [Google Scholar]
  43. Pollock N. J., Mirra S. S., Binder L. I., Hansen L. A., Wood J. G. Filamentous aggregates in Pick's disease, progressive supranuclear palsy, and Alzheimer's disease share antigenic determinants with microtubule-associated protein, tau. Lancet. 1986 Nov 22;2(8517):1211–1211. doi: 10.1016/s0140-6736(86)92212-9. [DOI] [PubMed] [Google Scholar]
  44. Prusiner S. B. Prions and neurodegenerative diseases. N Engl J Med. 1987 Dec 17;317(25):1571–1581. doi: 10.1056/NEJM198712173172505. [DOI] [PubMed] [Google Scholar]
  45. Prusiner S. B. Some speculations about prions, amyloid, and Alzheimer's disease. N Engl J Med. 1984 Mar 8;310(10):661–663. doi: 10.1056/NEJM198403083101021. [DOI] [PubMed] [Google Scholar]
  46. Robakis N. K., Devine-Gage E. A., Jenkins E. C., Kascsak R. J., Brown W. T., Krawczun M. S., Silverman W. P. Localization of a human gene homologous to the PrP gene on the p arm of chromosome 20 and detection of PrP-related antigens in normal human brain. Biochem Biophys Res Commun. 1986 Oct 30;140(2):758–765. doi: 10.1016/0006-291x(86)90796-5. [DOI] [PubMed] [Google Scholar]
  47. Sinet P. M., Lejeune J., Jerome H. Trisomy 21 (Down's syndrome). Glutathione peroxidase, hexose monophoshate shunt and I.Q. Life Sci. 1979 Jan 1;24(1):29–33. doi: 10.1016/0024-3205(79)90276-5. [DOI] [PubMed] [Google Scholar]
  48. St George-Hyslop P. H., Tanzi R. E., Polinsky R. J., Haines J. L., Nee L., Watkins P. C., Myers R. H., Feldman R. G., Pollen D., Drachman D. The genetic defect causing familial Alzheimer's disease maps on chromosome 21. Science. 1987 Feb 20;235(4791):885–890. doi: 10.1126/science.2880399. [DOI] [PubMed] [Google Scholar]
  49. Standaert D. G., Cechetto D. F., Needleman P., Saper C. B. Inhibition of the firing of vasopressin neurons by atriopeptin. Nature. 1987 Sep 10;329(6135):151–153. doi: 10.1038/329151a0. [DOI] [PubMed] [Google Scholar]
  50. TERRY R. D., PENA C. EXPERIMENTAL PRODUCTION OF NEUROFIBRILLARY DEGENERATION 2. ELECTRON MICROSCOPY, PHOSPHATASE HISTOCHEMISTRY AND ELECTRON PROBE ANALYSIS. J Neuropathol Exp Neurol. 1965 Apr;24:200–210. doi: 10.1097/00005072-196504000-00003. [DOI] [PubMed] [Google Scholar]
  51. Tanzi R. E., Bird E. D., Latt S. A., Neve R. L. The amyloid beta protein gene is not duplicated in brains from patients with Alzheimer's disease. Science. 1987 Oct 30;238(4827):666–669. doi: 10.1126/science.2890207. [DOI] [PubMed] [Google Scholar]
  52. Wesseling H., Agoston S., Van Dam G. B., Pasma J., DeWit D. J., Havinga H. Effects of 4-aminopyridine in elderly patients with Alzheimer's disease. N Engl J Med. 1984 Apr 12;310(15):988–989. doi: 10.1056/NEJM198404123101514. [DOI] [PubMed] [Google Scholar]
  53. Whalley L. J., Carothers A. D., Collyer S., De Mey R., Frackiewicz A. A study of familial factors in Alzheimer's disease. Br J Psychiatry. 1982 Mar;140:249–256. doi: 10.1192/bjp.140.3.249. [DOI] [PubMed] [Google Scholar]
  54. Wisniewski H. M., Sturman J. A., Shek J. W. Aluminum chloride induced neurofibrillary changes in the developing rabbit a chronic animal model. Ann Neurol. 1980 Nov;8(5):479–490. doi: 10.1002/ana.410080505. [DOI] [PubMed] [Google Scholar]
  55. Wright A. F., Whalley L. J. Genetics, ageing and dementia. Br J Psychiatry. 1984 Jul;145:20–38. doi: 10.1192/bjp.145.1.20. [DOI] [PubMed] [Google Scholar]
  56. Yanagihara R., Garruto R. M., Gajdusek D. C., Tomita A., Uchikawa T., Konagaya Y., Chen K. M., Sobue I., Plato C. C., Gibbs C. J., Jr Calcium and vitamin D metabolism in Guamanian Chamorros with amyotrophic lateral sclerosis and parkinsonism-dementia. Ann Neurol. 1984 Jan;15(1):42–48. doi: 10.1002/ana.410150108. [DOI] [PubMed] [Google Scholar]
  57. Zubenko G. S., Cohen B. M., Boller F., Malinakova I., Keefe N., Chojnacki B. Platelet membrane abnormality in Alzheimer's disease. Ann Neurol. 1987 Aug;22(2):237–244. doi: 10.1002/ana.410220208. [DOI] [PubMed] [Google Scholar]

Articles from BMJ : British Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES